Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance

International Journal of Antimicrobial Agents

Volumn 36, Issue 3, 2010, Pages 255-258

  Shimada, Yasushi ^a,b   Deguchi, Takashi ^a   Nakane, Keita ^a   Masue, Takako ^a   Yasuda, Mitsuru ^a   Yokoi, Shigeaki ^a   Ito, Shin ichi ^a   Nakano, Masahiro ^a   Ito, Shin ^c   Ishiko, Hiroaki ^b  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c IClinic   (Japan)

Author keywords

Fluoroquinolone resistance; GyrA; Mycoplasma genitalium; ParC

Indexed keywords

ARGININE; ASPARAGINE; ASPARTIC ACID; BACTERIAL DNA; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ISOLEUCINE; LYSINE; PHENYLALANINE; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; TYROSINE; VALINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; QUINOLONE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA EXTRACTION; GENE MUTATION; JAPAN; MYCOPLASMA GENITALIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRAIN IDENTIFICATION; UREAPLASMA; URINALYSIS; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MISSENSE MUTATION; MYCOPLASMOSIS; URETHRITIS;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; JAPAN; MALE; MUTATION, MISSENSE; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; URETHRITIS;

EID: 77954958494     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.05.011     Document Type: Article

References (15)

1. Tully J.G., Taylor-Robinson D., Cole R.M., Rose D.L. A newly discovered mycoplasma in the human urogenital tract. Lancet 1981, 1:1288-1291.
2. Mena L.A., Mroczkowski T.F., Nsuami M., Martin D.H. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009, 48:1649-1654.
3. Yasuda M., Maeda S., Deguchi T. In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of M. genitalium-positive nongonococcal urethritis in men. Clin Infect Dis 2005, 41:1357-1359.
4. Jernberg E., Moghaddam A., Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008, 19:676-679.
5. Bébéar C.M., Renaudin J., Charron A., Renaudin H., de Barbeyrac B., Schaeverbeke T., et al. Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis. Antimicrob Agents Chemother 1999, 43:954-956.
6. Gruson D., Pereyre S., Renaudin H., Charron A., Bébéar C., Bébéar C.M. In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively. Antimicrob Agents Chemother 2005, 49:1190-1193.
7. Lysnyansky I., Gerchman I., Perk S., Levisohn S. Molecular characterization and typing of enrofloxacin-resistant clinical isolates of Mycoplasma gallisepticum. Avian Dis 2008, 52:685-689.
8. Hirose K., Kawasaki Y., Kotani K., Abiko K., Sato H. Characterization of a point mutation in the parC gene of Mycoplasma bovirhinis associated with fluoroquinolone resistance. J Vet Med B Infect Dis Vet Public Health 2004, 51:169-175.
9. Le Carrou J., Reinhardt A.K., Kempf I., Gautier-Bouchardon A.V. Persistence of Mycoplasma synoviae in hens after two enrofloxacin treatments and detection of mutations in the parC gene. Vet Res 2006, 37:145-154.
10. Vicca J., Maes D., Stakenborg T., Butaye P., Minion F., Peeters J., et al. Resistance mechanism against fluoroquinolones in Mycoplasma hyopneumoniae field isolates. Microb Drug Resist 2007, 13:166-170.
11. Lysnyansky I., Mikula I., Gerchman I., Levisohn S. Rapid detection of a point mutation in the parC gene associated with decreased susceptibility to fluoroquinolones in Mycoplasma bovis. Antimicrob Agents Chemother 2009, 53:4911-4914.
12. Beeton M.L., Chalker V.J., Kotecha S., Spiller O.B. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism. J Antimicrob Chemother 2009, 64:529-538.
13. Yoshida H., Bogaki M., Nakamura M., Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 1990, 34:1271-1272.
14. Yoshida T., Maeda S., Deguchi T., Miyazawa T., Ishiko H. Rapid detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum organisms in genitourinary samples by PCR-microtiter plate hybridization assay. J Clin Microbiol 2003, 41:1850-1855.
15. Deguchi T., Maeda S., Tamaki M., Yoshida T., Ishiko H., Ito M., et al. Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment. J Antimicrob Chemother 2001, 48:742-744.